The DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
Antibiotics and Bacterial Resistance—A Short Story of an Endless Arms Race
Open accessAbstract
Despite the undisputed development of medicine, antibiotics still serve as first-choice drugs for patients with infectious disorders. The widespread use of antibiotics results from a wide spectrum of their actions encompassing mechanisms responsible for: the inhibition of bacterial cell wall biosynthesis, the disruption of cell membrane integrity, the suppression of nucleic acids and/or proteins synthesis, as well as disturbances of metabolic processes. However, the widespread availability of antibiotics, accompanied by their overprescription, acts as a double-edged sword, since the overuse and/or misuse of antibiotics leads to a growing number of multidrug-resistant microbes. This, in turn, has recently emerged as a global public health challenge facing both clinicians and their patients. In addition to intrinsic resistance, bacteria can acquire resistance to particular antimicrobial agents through the transfer of genetic material conferring resistance. Amongst the most common bacterial resistance strategies are: drug target site changes, increased cell wall permeability to antibiotics, antibiotic inactivation, and efflux pumps. A better understanding of the interplay between the mechanisms of antibiotic actions and bacterial defense strategies against particular antimicrobial agents is crucial for developing new drugs or drug combinations. Herein, we provide a brief overview of the current nanomedicine-based strategies that aim to improve the efficacy of antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
DNA Topoisomerases: Structure, Function, and Mechanism
Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,743
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Antimicrobial Resistance: Implications and Costs
Dadgostar, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s234610 · Cited by 2,024
An overview of the antimicrobial resistance mechanisms of bacteria
C Reygaert, W., & Department of Biomedical Sciences, O. U. W. B. S. O. M. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.3.482 · Cited by 1,893
Outer membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase
Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., & Darst, S. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00286-0 · Cited by 1,556
Carbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Poirel, L., Jayol, A., & Nordmann, P. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-16 · Cited by 1,447
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J.-M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,395
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis
Sauvage, E., Kerff, F., Terrak, M., Ayala, J. A., & Charlier, P. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00105.x · Cited by 1,317
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Aminoglycosides: Activity and Resistance
Mingeot-Leclercq, M.-P., Glupczynski, Y., & Tulkens, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.727 · Cited by 1,113
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Tipper, D. J., & Strominger, J. L. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.54.4.1133 · Cited by 1,008
Erythromycin resistance by ribosome modification
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.577 · Cited by 1,008
Peterson, E., & Kaur, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02928 · Cited by 1,006
The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
Pagès, J.-M., James, C. E., & Winterhalter, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1994 · Cited by 939
Human commensals producing a novel antibiotic impair pathogen colonization
Zipperer, A., Konnerth, M. C., Laux, C., Berscheid, A., Janek, D., Weidenmaier, C., Burian, M., Schilling, N. A., Slavetinsky, C., Marschal, M., et al. (2016) · Nature · doi:10.1038/nature18634 · Cited by 938
Mechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892
Levine, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/491709 · Cited by 838
Past and Present Perspectives on β-Lactamases
Bush, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01076-18 · Cited by 832
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota
Hu, Y., Yang, X., Qin, J., Lu, N., Cheng, G., Wu, N., Pan, Y., Li, J., Zhu, L., Wang, X., et al. (2013) · Nature Communications · doi:10.1038/ncomms3151 · Cited by 781
Structure−Activity Relationships of Polymyxin Antibiotics
Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780
Polymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759
Mechanisms of drug resistance: quinolone resistance
Hooper, D. C., & Jacoby, G. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12830 · Cited by 716
Ruiz, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg222 · Cited by 711
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions
Cox, G., & Wright, G. D. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.009 · Cited by 697
Molecular mechanisms of membrane targeting antibiotics
Epand, R. M., Walker, C., Epand, R. F., & Magarvey, N. A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.018 · Cited by 666
Glycopeptide and Lipoglycopeptide Antibiotics
Kahne, D., Leimkuhler, C., Lu, W., & Walsh, C. (2005) · Chemical Reviews · doi:10.1021/cr030103a · Cited by 662
Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus
Silverman, J. A., Perlmutter, N. G., & Shapiro, H. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2538-2544.2003 · Cited by 656
Sulfonamide resistance: mechanisms and trends.
Sköld, O. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0146 · Cited by 647
Versatility of Aminoglycosides and Prospects for Their Future
Vakulenko, S. B., & Mobashery, S. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.430-450.2003 · Cited by 643
Bacterial Cell Wall Synthesis: New Insights from Localization Studies
Scheffers, D.-J., & Pinho, M. G. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.585-607.2005 · Cited by 629
The Discovery of Penicillin—New Insights After More Than 75 Years of Clinical Use
Gaynes, R. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2305.161556 · Cited by 597
Terreni, M., Taccani, M., & Pregnolato, M. (2021) · Molecules · doi:10.3390/molecules26092671 · Cited by 596
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
Garneau-Tsodikova, S., & Labby, K. J. (2016) · MedChemComm · doi:10.1039/c5md00344j · Cited by 576
Quinolone-Mediated Bacterial Death
Drlica, K., Malik, M., Kerns, R. J., & Zhao, X. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01617-06 · Cited by 570
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 561
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance
Hooper, D. C., & Jacoby, G. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025320 · Cited by 553
RifamycinMode of Action, Resistance, and Biosynthesis
Floss, H. G., & Yu, T.-W. (2005) · Chemical Reviews · doi:10.1021/cr030112j · Cited by 547
The peptide antibiotics of Bacillus: chemistry, biogenesis, and possible functions
Katz, E., & Demain, A. L. (1977) · Bacteriological Reviews · doi:10.1128/br.41.2.449-474.1977 · Cited by 540
Yong, D., Lee, K., Yum, J. H., Shin, H. B., Rossolini, G. M., & Chong, Y. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3798-3801.2002 · Cited by 538
An enzyme from bacteria able to destroy penicillin. 1940.
Abraham, E. P., & Chain, E. B. (1988) · PubMed · Cited by 532
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
Lee, N.-Y., Ko, W.-C., & Hsueh, P.-R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01153 · Cited by 532
Bacterial resistance to antibiotics: Active efflux and reduced uptake
KUMAR, A., & SCHWEIZER, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.004 · Cited by 529
Tetracycline antibiotics and resistance mechanisms
Nguyen, F., Starosta, A. L., Arenz, S., Sohmen, D., Dönhöfer, A., & Wilson, D. N. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0292 · Cited by 528
Trimethoprim and sulfonamide resistance.
Huovinen, P., Sundström, L., Swedberg, G., & Sköld, O. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.279 · Cited by 523
AUREOMYCIN: A PRODUCT OF THE CONTINUING SEARCH FOR NEW ANTIBIOTICS
Duggar, B. M. (1948) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1948.tb27262.x · Cited by 512
The role of vaccines in combatting antimicrobial resistance
Micoli, F., Bagnoli, F., Rappuoli, R., & Serruto, D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00506-3 · Cited by 500
Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth
Comeau, A., Tétart, F., Trojet, S. N., Prère, M. F., & Krisch, H. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000799 · Cited by 488
The emergence of mecC methicillin-resistant Staphylococcus aureus
Paterson, G. K., Harrison, E. M., & Holmes, M. A. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.11.003 · Cited by 470
The history of the tetracyclines
Nelson, M. L., & Levy, S. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06354.x · Cited by 468
Tenson, T., Lovmar, M., & Ehrenberg, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00662-4 · Cited by 461
Polymyxin: Alternative Mechanisms of Action and Resistance
Trimble, M. J., Mlynárčik, P., Kolář, M., & Hancock, R. E. W. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025288 · Cited by 454
Country-specific antibiotic use practices impact the human gut resistome
Forslund, K., Sunagawa, S., Kultima, J. R., Mende, D. R., Arumugam, M., Typas, A., & Bork, P. (2013) · Genome Research · doi:10.1101/gr.155465.113 · Cited by 442
Ahmed, M. O., & Baptiste, K. E. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0147 · Cited by 438
Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains
Müller, A., Wenzel, M., Strahl, H., Grein, F., Saaki, T. N. V., Kohl, B., Siersma, T., Bandow, J. E., Sahl, H.-G., Schneider, T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611173113 · Cited by 425
Kinship and Diversification of Bacterial Penicillin-Binding Proteins and β-Lactamases
Massova, I., & Mobashery, S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.1 · Cited by 422
Tetracyclines, molecular and clinical aspects
Chopra, I., Hawkey, P. M., & Hinton, M. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.3.245 · Cited by 421
The emergence of antibiotic resistance by mutation
Woodford, N., & Ellington, M. J. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01492.x · Cited by 417
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance
Bush, N. G., Diez-Santos, I., Abbott, L. R., & Maxwell, A. (2020) · Molecules · doi:10.3390/molecules25235662 · Cited by 413
Resistance to rifampicin: a review
Goldstein, B. P. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.107 · Cited by 409
Oxazolidinones: activity, mode of action, and mechanism of resistance
Bozdogan, B., & Appelbaum, P. C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.11.003 · Cited by 403
The natural history of antibiotics
Clardy, J., Fischbach, M. A., & Currie, C. R. (2009) · Current Biology · doi:10.1016/j.cub.2009.04.001 · Cited by 402
Pinho, M. G., de Lencastre, H., & Tomasz, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191260798 · Cited by 384
Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin
Sato, T., & Yamawaki, K. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz826 · Cited by 379
Howden, B. P., McEvoy, C. R. E., Allen, D. L., Chua, K., Gao, W., Harrison, P. F., Bell, J., Coombs, G., Bennett-Wood, V., Porter, J. L., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002359 · Cited by 370
TetX Is a Flavin-dependent Monooxygenase Conferring Resistance to Tetracycline Antibiotics
Yang, W., Moore, I. F., Koteva, K. P., Bareich, D. C., Hughes, D. W., & Wright, G. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409573200 · Cited by 364
Vancomycin Assembly: Nature's Way
Hubbard, B. K., & Walsh, C. T. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390202 · Cited by 356
Wise, E. M., & Park, J. T. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.54.1.75 · Cited by 347
Gooderham, W. J., & Hancock, R. E. W. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00135.x · Cited by 346
Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy
Tagliaferri, T. L., Jansen, M., & Horz, H.-P. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00022 · Cited by 345
Doi, Y., Wachino, J.-I., & Arakawa, Y. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.011 · Cited by 341
Molecular understanding of aminoglycoside action and resistance
Jana, S., & Deb, J. K. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0279-0 · Cited by 336
Mechanisms of quinolone action and resistance: where do we stand?
Correia, S., Poeta, P., Hébraud, M., Capelo, J. L., & Igrejas, G. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000475 · Cited by 332
A White-Box Machine Learning Approach for Revealing Antibiotic Mechanisms of Action
Yang, J. H., Wright, S. N., Hamblin, M., McCloskey, D., Alcantar, M. A., Schrübbers, L., Lopatkin, A. J., Satish, S., Nili, A., Palsson, B. O., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.016 · Cited by 321
Wilson, D. N., Schluenzen, F., Harms, J. M., Starosta, A. L., Connell, S. R., & Fucini, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804276105 · Cited by 318
Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding d -Ala- d -Ala
Ge, M., Chen, Z., Russell, H., Onishi, Kohler, J., Silver, L. L., Kerns, R., Fukuzawa, S., Thompson, C., & Kahne, D. (1999) · Science · doi:10.1126/science.284.5413.507 · Cited by 318
β-Lactamases: A Focus on Current Challenges
Bonomo, R. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025239 · Cited by 318
Matsuhashi, M., Song, M. D., Ishino, F., Wachi, M., Doi, M., Inoue, M., Ubukata, K., Yamashita, N., & Konno, M. (1986) · Journal of Bacteriology · doi:10.1128/jb.167.3.975-980.1986 · Cited by 316
Konovalova, A., Kahne, D. E., & Silhavy, T. J. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093754 · Cited by 314
Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections
Stracy, M., Snitser, O., Yelin, I., Amer, Y., Parizade, M., Katz, R., Rimler, G., Wolf, T., Herzel, E., Koren, G., et al. (2022) · Science · doi:10.1126/science.abg9868 · Cited by 304
Crystal Structure of the Oxazolidinone Antibiotic Linezolid Bound to the 50S Ribosomal Subunit
Ippolito, J. A., Kanyo, Z. F., Wang, D., Franceschi, F. J., Moore, P. B., Steitz, T. A., & Duffy, E. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800379d · Cited by 303
The action mechanism of daptomycin
Taylor, S. D., & Palmer, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.052 · Cited by 298
Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase
Achari, A., Somers, D. 0., Champness, J. N., Bryant, P. K., Rosemond, J., & Stammers, D. K. (1997) · Natural Structural Biology · doi:10.1038/nsb0697-490 · Cited by 297
Sawa, T., Kooguchi, K., & Moriyama, K. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-0429-6 · Cited by 296
Davis, B. D., Chen, L. L., & Tai, P. C. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.6164 · Cited by 293
Gut microbiota as a source of novel antimicrobials
Garcia-Gutierrez, E., Mayer, M. J., Cotter, P. D., & Narbad, A. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1455790 · Cited by 292
Mechanisms of quinolone action and microbial response
Hawkey, P. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg207 · Cited by 288
Why big pharma has abandoned antibiotics
Plackett, B. (2020) · Nature · doi:10.1038/d41586-020-02884-3 · Cited by 278
Solomkin, J., Evans, D., Slepavicius, A., Lee, P., Marsh, A., Tsai, L., Sutcliffe, J. A., & Horn, P. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2016.4237 · Cited by 276
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering
Baltz, R. H. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.02.031 · Cited by 267
Uluseker, C., Kaster, K. M., Thorsen, K., Basiry, D., Shobana, S., Jain, M., Kumar, G., Kommedal, R., & Pala-Ozkok, I. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.717809 · Cited by 260
The oxazolidinones: past, present, and future
Shaw, K. J., & Barbachyn, M. R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06330.x · Cited by 259
Inhibitors of FabI, an Enzyme Drug Target in the Bacterial Fatty Acid Biosynthesis Pathway
Lu, H., & Tonge, P. J. (2008) · Accounts of Chemical Research · doi:10.1021/ar700156e · Cited by 254
Origins of the Quinolone Class of Antibacterials: An Expanded “Discovery Story”: Miniperspective
Bisacchi, G. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501881c · Cited by 252
Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro
Ryan, E. M., Alkawareek, M. Y., Donnelly, R. F., & Gilmore, B. F. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00977.x · Cited by 240
Shakil, S., Khan, R., Zarrilli, R., & Khan, A. U. (2008) · Journal of Biomedical Science · doi:10.1007/s11373-007-9194-y · Cited by 230
Greene, N. P., Kaplan, E., Crow, A., & Koronakis, V. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00950 · Cited by 228
Macrolide Resistance Genes in Enterococcus spp
Portillo, A., Ruiz-Larrea, F., Zarazaga, M., Alonso, A., Martinez, J. L., & Torres, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.967-971.2000 · Cited by 227
Zaw, M. T., Emran, N. A., & Lin, Z. (2018) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2018.04.005 · Cited by 224
The origins and molecular basis of antibiotic resistance
Hawkey, P. M. (1998) · BMJ · doi:10.1136/bmj.317.7159.657 · Cited by 221
Mechanisms of Polymyxin Resistance
Moffatt, J. H., Harper, M., & Boyce, J. D. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-16373-0_5 · Cited by 220
Hebeisen, P., Heinze-Krauss, I., Angehrn, P., Hohl, P., Page, M. G. P., & Then, R. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.825-836.2001 · Cited by 219
Clinical Pharmacology of Antibiotics
Eyler, R. F., & Shvets, K. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08140718 · Cited by 212
Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance
Zeng, D., Debabov, D., Hartsell, T. L., Cano, R. J., Adams, S., Schuyler, J. A., McMillan, R., & Pace, J. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026989 · Cited by 211
The Prehistory of Antibiotic Resistance
Perry, J., Waglechner, N., & Wright, G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025197 · Cited by 210
Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance
Ayoub Moubareck, C. (2020) · Membranes · doi:10.3390/membranes10080181 · Cited by 206
rRNA Binding Sites and the Molecular Mechanism of Action of the Tetracyclines
Chukwudi, C. U. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00594-16 · Cited by 204
Rice, L. B. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.12.003 · Cited by 201
Plasmid-Encoded Transferable mecB-Mediated Methicillin Resistance in Staphylococcus aureus
Becker, K., van Alen, S., Idelevich, E. A., Schleimer, N., Seggewiß, J., Mellmann, A., Kaspar, U., & Peters, G. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2402.171074 · Cited by 200
A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics
Sarkar, P., Yarlagadda, V., Ghosh, C., & Haldar, J. (2017) · MedChemComm · doi:10.1039/c6md00585c · Cited by 199
Two-component systems required for virulence in Pseudomonas aeruginosa
Francis, V. I., Stevenson, E. C., & Porter, S. L. (2017) · FEMS Microbiology Letters · doi:10.1093/femsle/fnx104 · Cited by 199
Macrolide Resistance in Streptococcus pneumoniae
Schroeder, M. R., & Stephens, D. S. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00098 · Cited by 198
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
Wu, J. Y., Srinivas, P., & Pogue, J. M. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00286-6 · Cited by 195
Do we still need the aminoglycosides?
Durante-Mangoni, E., Grammatikos, A., Utili, R., & Falagas, M. E. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.09.001 · Cited by 193
Type II Topoisomerases as Targets for Quinolone Antibacterials Turning Dr. Jekyll into Mr. Hyde
Anderson, V., & Osheroff, N. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013398013 · Cited by 190
Tetracycline-Inactivating Enzymes
Markley, J. L., & Wencewicz, T. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01058 · Cited by 188
Douthwaite, S., Hansen, L. H., & Mauvais, P. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01841.x · Cited by 187
Hassan, K. A., Liu, Q., Henderson, P. J. F., & Paulsen, I. T. (2015) · mBio · doi:10.1128/mbio.01982-14 · Cited by 181
Development of Liposomal Ciprofloxacin to Treat Lung Infections
Cipolla, D., Blanchard, J., & Gonda, I. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8010006 · Cited by 177
Antibiotic Resistance: From the Bench to Patients
Gajdács, M., & Alberício, F. (2019) · Antibiotics · doi:10.3390/antibiotics15060625 · Cited by 177
Chakraborty, N., Jha, D., Roy, I., Kumar, P., Gaurav, S. S., Marimuthu, K., Ng, O.-T., Lakshminarayanan, R., Verma, N. K., & Gautam, H. K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01573-9 · Cited by 173
New target for inhibition of bacterial RNA polymerase: ‘switch region’
Srivastava, A., Talaue, M., Liu, S., Degen, D., Ebright, R. Y., Sineva, E., Chakraborty, A., Druzhinin, S. Y., Chatterjee, S., Mukhopadhyay, J., et al. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.030 · Cited by 172
Bacterial Protein Synthesis as a Target for Antibiotic InhibitionPreprint
Arenz, S., & Wilson, D. N. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025361 · Cited by 170
Cheng, H.-Y., Chen, Y.-F., & Peng, H.-L. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-60 · Cited by 166
Development of novel nanoantibiotics using an outer membrane vesicle-based drug efflux mechanism
Huang, W., Zhang, Q., Li, W., Yuan, M., Zhou, J., Hua, L., Chen, Y., Ye, C., & Ma, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.017 · Cited by 165
Old and New Glycopeptide Antibiotics: Action and Resistance
Binda, E., Marinelli, F., & Marcone, G. (2014) · Antibiotics · doi:10.3390/antibiotics3040572 · Cited by 164
Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic
Grossman, T. H., Starosta, A. L., Fyfe, C., O'Brien, W., Rothstein, D. M., Mikolajka, A., Wilson, D. N., & Sutcliffe, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06187-11 · Cited by 162
Vaccines Against Antimicrobial Resistance
Rosini, R., Nicchi, S., Pizza, M., & Rappuoli, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01048 · Cited by 160
Discovery of Antibiotic ( E )-3-(3-Carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3 H )-one
Bouley, R. A., Kumarasiri, M., Peng, Z., Otero, L. H., Song, W., Suckow, M. A., Schroeder, V. A., Wolter, W. R., Lastochkin, E., Antunes, N. T., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b00056 · Cited by 157
Labby, K. J., & Garneau‐Tsodikova, S. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.80 · Cited by 154
Targeting Antibacterial Agents by Using Drug-Carrying Filamentous Bacteriophages
Yacoby, I., Shamis, M., Bar, H., Shabat, D., & Benhar, I. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00169-06 · Cited by 152
Macrolides and lincosamides in cattle and pigs: Use and development of antimicrobial resistance
Pyörälä, S., Baptiste, K. E., Catry, B., van Duijkeren, E., Greko, C., Moreno, M. Á., Pomba, C., Rantala, M. H. J., Ružauskas, M., Sandérs, P., et al. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.02.028 · Cited by 151
Eyal, Z., Matzov, D., Krupkin, M., Wekselman, I., Paukner, S., Zimmerman, E., Rozenberg, H., Bashan, A., & Yonath, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517952112 · Cited by 151
Adrian, P. V., & Klugman, K. P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2406 · Cited by 149
Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones
Roger, C., Roberts, J. A., & Müller, L. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0601-x · Cited by 149
Koch, A. S., Mizrahi, V., & Warner, D. F. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.17 · Cited by 147
Srinivasan, V. B., Rajamohan, G., & Gebreyes, W. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00748-09 · Cited by 145
Rifamycins, Alone and in CombinationPreprint
Rothstein, D. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027011 · Cited by 145
Amin, N. M. E., Giske, C. G., Jalal, S., KEIJSER, B., Kronvall, G., & Wretlind, B. (2005) · Apmis · doi:10.1111/j.1600-0463.2005.apm1130306.x · Cited by 142
Doménech‐Sánchez, A., Hernández-Allés, S., Martı́nez-Martı́nez, L., Benedi, V. J., & Albertí, S. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.9.2726-2732.1999 · Cited by 140
Look and Outlook on Enzyme-Mediated Macrolide Resistance
Golkar, T., Zieliński, M., & Berghuis, A. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01942 · Cited by 140
Antibacterial action of quinolones: From target to network
Cheng, G., Hao, H., Dai, M., Liu, Z., & Yuan, Z. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.057 · Cited by 139
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections
Heo, Y. (2021) · Drugs · doi:10.1007/s40265-021-01471-8 · Cited by 139
Reynolds, P. E., & Courvalin, P. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.21-25.2005 · Cited by 138
Rouquette, C., Dunham, S. A., Kuhn, M., Balthazar, J. T., & Shafer, W. M. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.3.1101-1106.2003 · Cited by 134
Structures of RNA polymerase–antibiotic complexes
Ho, M. X., Hudson, B. P., Das, K., Arnold, E., & Ebright, R. H. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.10.010 · Cited by 127
Huang, J., Li, C., Song, J., Velkov, T., Wang, L., Zhu, Y., & Li, J. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0322 · Cited by 123
Eravacycline: A Review in Complicated Intra-Abdominal Infections
Scott, L. J. (2019) · Drugs · doi:10.1007/s40265-019-01067-3 · Cited by 120
Redesign of Glycopeptide Antibiotics: Back to the Future
James, R. C., Pierce, J. G., Okano, A., Xie, J. H., & Boger, D. L. (2012) · ACS Chemical Biology · doi:10.1021/cb300007j · Cited by 118
Zaman, S., Fitzpatrick, M., Lindahl, L., & Zengel, J. M. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05975.x · Cited by 117
Molecular mechanisms of bacterial resistance to antimicrobial agents
Kumar, S. H., & Varela, M. F. (2013) · Cited by 116
Khalifa, S. M., El-Aziz, A. M. A., Hassan, R., & Abdelmegeed, E. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251594 · Cited by 114
Frère, J., Duez, C., & Ghuysen, J. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80770-3 · Cited by 111
An Update on Eight “New” Antibiotics against Multidrug-Resistant Gram-Negative Bacteria
Yusuf, E., Bax, H. I., Verkaik, N. J., & van Westreenen, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051068 · Cited by 111
Ansamycins chemistry, biosynthesis and biological activity
Wehrli, W. (2006) · Topics in Current Chemistry · doi:10.1007/bfb0048448 · Cited by 110
Schmitz, F., Hofmann, B., Hansen, B., Scheuring, S., Lückefahr, M., Klootwijk, M., Verhoef, J., Fluit, A., Heinz, H. P., Köhrer, K., et al. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.4.481 · Cited by 108
Schwendener, S., Cotting, K., & Perreten, V. (2017) · Scientific Reports · doi:10.1038/srep43797 · Cited by 107
Zhao, W., Zhong, Y., Yuan, H., Wang, J., Zheng, H., Wang, Y., Cen, X., Xu, F., Bai, J., Han, X., et al. (2010) · Cell Research · doi:10.1038/cr.2010.87 · Cited by 105
Gómez-Gómez, C., Blanco‐Picazo, P., Brown-Jaque, M., Quirós, P., Rodríguez‐Rubio, L., Cerdà‐Cuéllar, M., & Muniesa, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-49898-0 · Cited by 99
Dual Effects of MLS Antibiotics
Tsui, W. H. W., Yim, G., Wang, H. H., McClure-Warnier, J.-A., Surette, M. G., & DAVIES, J. E. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.07.010 · Cited by 98
Ribosomal RNA and protein mutants resistant to spectinomycin.
Bilgin, N., Richter, A. A., Ehrenberg, M., Dahĺberg, A. E., & Kurland, C. G. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08167.x · Cited by 97
Mechanisms of bactericidal action and resistance of polymyxins for Gram-positive bacteria
Yin, J., Meng, Q., Cheng, D., Fu, J., Luo, Q., Liu, Y., & Yu, Z. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10525-y · Cited by 97
Hamad, M. A., Lorenzo, F. D., Molinaro, A., & Valvano, M. A. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08154.x · Cited by 95
Fermér, C., Kristiansen, B., Sköld, O., & Swedberg, G. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.16.4669-4675.1995 · Cited by 94
DAPTOMYCIN, its membrane-active mechanism vs. that of other antimicrobial peptides
Huang, H. W. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183395 · Cited by 92
Johnson, L., Horsman, S. R., Charron‐Mazenod, L., Turnbull, A. L., Mulcahy, H., Surette, M. G., & Lewenza, S. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-115 · Cited by 91
Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria
Yarlagadda, V., Manjunath, G. B., Sarkar, P., Akkapeddi, P., Krishnamoorthy, P., Shome, B. R., Ravikumar, R., & Haldar, J. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00114 · Cited by 91
Current Promising Strategies against Antibiotic-Resistant Bacterial Infections
Ye, J.-Z., & Chen, X. (2022) · Antibiotics · doi:10.3390/antibiotics12010067 · Cited by 91
Giles, A. B., Foushee, J. A., Lantz, E., & Gumina, G. (2019) · Pharmacy · doi:10.3390/pharmacy7030132 · Cited by 90
Tedizolid Phosphate: a Next-Generation Oxazolidinone
Rybak, J. M., & Roberts, K. D. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0060-3 · Cited by 89
Champney, W. S., & Burdine, R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.2141 · Cited by 89
Galbadage, T., Liu, D., Alemany, L. B., Pál, R., Tour, J. M., Gunasekera, R. S., & Cirillo, J. D. (2019) · ACS Nano · doi:10.1021/acsnano.9b07836 · Cited by 87
Molecular Contacts Between Antibiotics and the 30S Ribosomal Particle
Wirmer, J., & Westhof, É. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)15012-0 · Cited by 86
Living with sulfonamides: a diverse range of mechanisms observed in bacteria
Nunes, O. C., Manaia, C. M., Kolvenbach, B. A., & Corvini, P. F.-X. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10982-5 · Cited by 85
Pohlhaus, J. R., & Kreuzer, K. N. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04638.x · Cited by 80
Microbiota-mediated protection against antibiotic-resistant pathogens
Panwar, R., Sequeira, R. P., & Clarke, T. B. (2021) · Genes and Immunity · doi:10.1038/s41435-021-00129-5 · Cited by 80
Fermér, C., & Swedberg, G. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.3.831-837.1997 · Cited by 79
There is no market for new antibiotics: this allows an open approach to research and development
Klug, D. M., Idiris, F. I. M., Blaskovich, M. A. T., von Delft, F., Dowson, C. G., Kirchhelle, C., Roberts, A. P., Singer, A. C., & Todd, M. H. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16847.1 · Cited by 79
Leener, E. D., Martel, A., Decostere, A., & Haesebrouck, F. (2004) · Microbial Drug Resistance · doi:10.1089/mdr.2004.10.341 · Cited by 78
Janardhanan, J., Bouley, R. A., Martínez‐Caballero, S., Peng, Z., Batuecas-Mordillo, M., Meisel, J. E., Ding, D., Schroeder, V. A., Wolter, W. R., Mahasenan, K. V., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02637-18 · Cited by 78
Matzaras, R., Nikopoulou, A., Protonotariou, E., & Christaki, E. (2022) · PubMed Central · Cited by 77
Allen, N. E., LeTourneau, D. L., & Hobbs, J. N. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.66 · Cited by 76
Mechanism of sulfonamide resistance in clinical isolates of Streptococcus pneumoniae
Maskell, J. P., Sefton, A. M., & Hall, L. M. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2121 · Cited by 75
Huang, E., & Yousef, A. E. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.03775-13 · Cited by 72
Metadata
- Authors
- Baran, A., Kwiatkowska, A., & Potocki, L.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-03-17
- Volume
- 24
- Issue
- 6
- Pages
- 5777
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4327968183
- Cited by
- 300
- References
- 247
- FWCI
- 21.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.